Cargando…

Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and has high mortality. Biomarkers related to HCC, such as alpha-fetoprotein, and imaging technology, such as ultrasound and computed tomography, have been used to screen and monitor HCC, but HCC is still difficult to diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Ting, Li, Li, Wu, Shaobo, Liu, Yan, Guo, Caiping, Wang, Wen, Dai, Lili, Zhang, Tong, Wu, Hao, Su, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991745/ https://www.ncbi.nlm.nih.gov/pubmed/33777736 http://dx.doi.org/10.3389/fonc.2021.583714

Ejemplares similares

New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
por: Wang, Ting, et al.
Publicado: (2020)

Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer
por: Lin, Xinqing, et al.
Publicado: (2021)

Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma
por: Lin, Zuyuan, et al.
Publicado: (2023)

Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma
por: Kohansal-Nodehi, Mahdokht, et al.
Publicado: (2023)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy
por: Jiang, Meilin, et al.
Publicado: (2020)

Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma
por: Li, Tian-Hao, et al.
Publicado: (2021)

Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma
por: Zhou, Wen-Da, et al.
Publicado: (2022)

Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma
por: Chen, Xiongfeng, et al.
Publicado: (2022)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma
por: Liu, Tiantian, et al.
Publicado: (2022)

Evaluation of the Efficiency of MRI-Based Radiomics Classifiers in the Diagnosis of Prostate Lesions
por: Li, Linghao, et al.
Publicado: (2022)

Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
por: Su, Wen-Jing, et al.
Publicado: (2021)

Abnormal ECA-Binding Membrane Glycans and Galactosylated CAT and P4HB in Lesion Tissues as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis
por: Kong, Ying, et al.
Publicado: (2022)

Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection
por: Li, Pinxiong, et al.
Publicado: (2021)

Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma
por: Luo, Qiong, et al.
Publicado: (2020)

Current perspectives on clinical use of exosomes as novel biomarkers for cancer diagnosis
por: Yi, Xiaomei, et al.
Publicado: (2022)

Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma
por: Chen, Jing, et al.
Publicado: (2022)

Plasma CXCL14 as a Candidate Biomarker for the Diagnosis of Lung Cancer
por: Tian, Peng-Fei, et al.
Publicado: (2022)

Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
por: Kim, Su-Hyun, et al.
Publicado: (2022)

The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes
por: Shi, Cong, et al.
Publicado: (2022)

Cancer Genomic Alterations Can Be Potential Biomarkers Predicting Microvascular Invasion and Early Recurrence of Hepatocellular Carcinoma
por: Xin, Zhaodan, et al.
Publicado: (2022)

Clinical Value of Machine Learning-Based Ultrasomics in Preoperative Differentiation Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Multicenter Study
por: Ren, Shanshan, et al.
Publicado: (2021)

Ultrasomics prediction for cytokeratin 19 expression in hepatocellular carcinoma: A multicenter study
por: Zhang, Linlin, et al.
Publicado: (2022)

Corrigendum: Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers
por: Kim, Su-Hyun, et al.
Publicado: (2023)

Exosomes in Pathogenesis, Diagnosis, and Treatment of Hepatocellular Carcinoma
por: Li, Shuang, et al.
Publicado: (2022)

The association between CTSZ methylation in peripheral blood and breast cancer in Chinese women
por: Li, Jinyu, et al.
Publicado: (2023)

Circulating tumor cells in peripheral blood as a diagnostic biomarker of breast cancer: A meta-analysis
por: Jin, Tao, et al.
Publicado: (2023)

CD4(+) Memory Stem T Cell in Peripheral Blood: A Promising Immune Index for Early Screening and Auxiliary Diagnosis of Colorectal Cancer
por: Lu, Yan, et al.
Publicado: (2021)

Methylation of Immune-Related Genes in Peripheral Blood Leukocytes and Breast Cancer
por: Tian, Tian, et al.
Publicado: (2022)

Genetic Polymorphisms in CD35 Gene Contribute to the Susceptibility and Prognosis of Hepatocellular Carcinoma
por: Luo, Limei, et al.
Publicado: (2021)

Systemic therapies in hepatocellular carcinoma: Existing and emerging biomarkers for treatment response
por: He, Penghui, et al.
Publicado: (2022)

A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
por: Lin, Yu, et al.
Publicado: (2022)

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients
por: Jia, Bin, et al.
Publicado: (2023)

Profiling and Integrated Analysis of Differentially Expressed MicroRNAs as Novel Biomarkers of Hepatocellular Carcinoma
por: Xie, Yuwei, et al.
Publicado: (2022)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
por: Guo, Zhanjun, et al.
Publicado: (2022)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Cai, Chenhui, et al.
Publicado: (2021)

Novel Prognostic Biomarkers in Metastatic and Locally Advanced Colorectal Cancer: Micronuclei Frequency and Telomerase Activity in Peripheral Blood Lymphocytes
por: Nikolouzakis, Taxiarchis Konstantinos, et al.
Publicado: (2021)

PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma
por: Su, Ke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0kmvhph2gqk355tvkpm3snrukf